{"gene":"BCL11B","run_date":"2026-04-28T17:12:38","timeline":{"discoveries":[{"year":2007,"finding":"CTIP2/BCL11B recruits histone deacetylases HDAC1 and HDAC2 to the HIV-1 promoter to promote local histone H3 deacetylation, and associates with histone methyltransferase SUV39H1 to increase H3K9 methylation, enabling HP1 protein recruitment and heterochromatin formation that silences HIV-1 transcription in microglial cells.","method":"ChIP, co-IP, transfection/reporter assays, pharmacological inhibition","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal biochemical methods (ChIP, co-IP, enzymatic assays) in a single rigorous study","pmids":["17245431"],"is_preprint":false},{"year":2003,"finding":"CTIP2/BCL11B interacts with HP1α and HIV-1 Tat protein to form a three-protein complex, relocalizing Tat into CTIP2-induced nuclear heterochromatic structures via two distinct CTIP2 domains (aa 145-434 interacting with Tat N-terminus; aa 717-813 interacting with HP1), thereby inhibiting Tat-mediated HIV-1 transactivation.","method":"Co-IP, confocal microscopy, deletion mutagenesis, reporter assays","journal":"Journal of virology","confidence":"High","confidence_rationale":"Tier 1-2 — domain mapping with deletion mutants plus co-IP and imaging, multiple orthogonal methods","pmids":["12692243"],"is_preprint":false},{"year":2006,"finding":"CTIP2/BCL11B associates with the NuRD chromatin-remodeling/deacetylase complex through direct interaction with RbAp46 and RbAp48; NuRD components are recruited to a promoter template in a CTIP2-dependent manner, and both CTIP2 and NuRD co-occupy the p57KIP2 promoter to repress its transcription.","method":"Co-IP, pulldown, ChIP, reporter assays in SK-N-MC neuroblastoma cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1-2 — direct interaction demonstrated by pulldown, ChIP co-occupancy, and reporter assays","pmids":["16950772"],"is_preprint":false},{"year":2009,"finding":"CTIP2/BCL11B and SUV39H1 are co-recruited to the p21WAF1 gene promoter, where CTIP2 cooperates with SUV39H1 to promote H3K9 trimethylation and silence p21 transcription; chaetocin (SUV39H1 inhibitor) treatment relieves this repression.","method":"ChIP, siRNA knockdown, pharmacological inhibition, reporter assays","journal":"Oncogene","confidence":"High","confidence_rationale":"Tier 1-2 — ChIP plus functional rescue with pharmacological inhibitor and knockdown","pmids":["19581932"],"is_preprint":false},{"year":2013,"finding":"CTIP2/BCL11B is a negative regulator of P-TEFb: it copurifies and directly interacts with HEXIM1 and, via the 7SK snRNA loop 2, with P-TEFb to form an inactive complex, significantly repressing CDK9 kinase activity and thereby suppressing P-TEFb-sensitive gene expression including at the MYH7 promoter in cardiomyopathic hearts.","method":"Co-purification, co-IP, in vitro CDK9 kinase assay, ChIP, siRNA knockdown, genome-wide transcriptomics","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — in vitro kinase assay plus multiple co-IP and ChIP experiments, genome-wide validation","pmids":["23852730"],"is_preprint":false},{"year":2010,"finding":"BCL11B is required for T lineage commitment in mice; it specifically represses natural killer cell-associated genes and downregulates stem/progenitor cell genes at the DN2-to-DN3 transition stage.","method":"Bcl11b knockout mouse model, gene expression profiling, flow cytometry","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cellular phenotype and gene expression readout, replicated across labs","pmids":["20595614"],"is_preprint":false},{"year":2010,"finding":"Deletion of Bcl11b in T cells causes them to acquire NK cell properties (morphologically and genetically similar to conventional NK cells) with retained tumor-killing capacity, demonstrating Bcl11b is required to maintain T cell identity and suppress NK cell programming.","method":"Conditional Bcl11b knockout, gene expression profiling, functional cytotoxicity assays, in vivo tumor metastasis model","journal":"Science (New York, N.Y.)","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with multiple orthogonal functional readouts, replicated concept across labs","pmids":["20538915"],"is_preprint":false},{"year":2003,"finding":"Bcl11b is required for Tcrb V(D)J recombination (specifically Vβ-to-Dβ joining), pre-TCR complex surface expression, and thymocyte survival; Bcl11b-deficient mice are blocked at the CD4−CD8− double-negative stage with profound thymic apoptosis.","method":"Bcl11b knockout mouse model, flow cytometry, PCR-based recombination assay, Northern blot","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 — clean KO with specific molecular and cellular phenotype; foundational paper with >300 citations","pmids":["12717433"],"is_preprint":false},{"year":2007,"finding":"BCL11B controls positive selection of both CD4 and CD8 thymocytes by maintaining proximal TCR signaling components; BCL11B-deficient DP thymocytes show impaired ERK phosphorylation and calcium flux, and increased spontaneous apoptosis associated with elevated caspase-3 cleavage and altered pro-/anti-apoptotic factor balance, only partially rescued by BCL2 transgene.","method":"Conditional knockout, flow cytometry, calcium flux assay, ERK phosphorylation assay, transgenic TCR rescue experiments, apoptosis assays","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal functional assays including rescue experiments","pmids":["17998389"],"is_preprint":false},{"year":2008,"finding":"Ctip2/BCL11B acts downstream of Fezf2 to regulate subcortical axon projection fate in the cerebral cortex; ectopic Ctip2 expression redirects callosal neurons to project subcortically and rescues the axonal phenotype of Fezf2 knockout mice.","method":"Knockout mice, in utero electroporation, axon tracing, epistasis analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with rescue experiment, multiple orthogonal readouts","pmids":["18678899"],"is_preprint":false},{"year":2008,"finding":"Ctip2/BCL11B is required for medium spiny neuron (MSN) differentiation and striatal architecture; Ctip2-null mice show dramatically reduced expression of MSN markers (DARPP-32, FOXP1, Chrm4, Reelin, MOR1, GluR1, Plexin-D1), failure of MSN patch aggregation, and abnormal dopaminergic innervation.","method":"Ctip2 knockout mouse model, immunohistochemistry, in situ hybridization, gene expression analysis","journal":"The Journal of neuroscience : the official journal of the Society for Neuroscience","confidence":"High","confidence_rationale":"Tier 2 — clean KO with multiple specific molecular and anatomical readouts","pmids":["18199763"],"is_preprint":false},{"year":2016,"finding":"Bcl11b expression is activated by an asynchronous combination of four regulatory inputs: TCF-1 and GATA-3 provide early locus 'poising', Notch signaling provides stochastic permissivity, and Runx1 controls amplitude; these act via a far downstream enhancer (Major Peak, ~850 kb from the Bcl11b promoter) that loops to interact with the promoter.","method":"Bcl11b knock-in fluorescent reporter mice, single-cell live imaging, genetic deletion of transcription factors, looping/enhancer assays","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 2 — single-cell reporter system with systematic genetic dissection of four factors","pmids":["27376470"],"is_preprint":false},{"year":2013,"finding":"A 1.9-kb enhancer element ('Major Peak') located ~850 kb downstream of Bcl11b is required for T-cell-specific Bcl11b expression; it contains TCF-1 binding sites and a conserved element needed for T-lineage activation and silencing in non-T cells, and physically loops to interact with the Bcl11b promoter-proximal region.","method":"Stable reporter assays, bacterial artificial chromosome transgenics, chromatin looping assays, deletion mutagenesis","journal":"Blood","confidence":"High","confidence_rationale":"Tier 1-2 — enhancer function confirmed by stable reporter and BAC transgenics with mutagenesis","pmids":["23741008"],"is_preprint":false},{"year":2011,"finding":"LSD1 histone demethylase cooperates with CTIP2 to repress HIV-1 transcription; LSD1 is recruited to the HIV-1 proximal promoter where its activity is associated with H3K4me3 and H3K9me3 epigenetic marks, and LSD1-induced H3K4 trimethylation is linked to hSET1 recruitment.","method":"ChIP, siRNA knockdown, reporter assays, co-IP","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP and co-IP from single lab","pmids":["22067449"],"is_preprint":false},{"year":2014,"finding":"HMGA1 recruits the CTIP2-repressed inactive P-TEFb/7SK snRNP complex to cellular gene promoters and the HIV-1 promoter; knockdown of HMGA1 reduces ChIP signal for CTIP2/7SK/P-TEFb at these promoters, and CTIP2 and HMGA1 act synergistically to repress P-TEFb-dependent gene expression.","method":"ChIP, siRNA dual knockdown, reporter assays, co-IP","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP and functional knockdown, single lab","pmids":["24623795"],"is_preprint":false},{"year":2012,"finding":"Bcl11b/Ctip2 regulates hippocampal dentate gyrus postnatal neurogenesis through a dual mechanism: feedback control of the progenitor cell compartment and regulation of granule cell differentiation; Desmoplakin is identified as a direct transcriptional target of Bcl11b, and re-expression of Desmoplakin in Bcl11b mutants rescues impaired neurogenesis.","method":"Forebrain-specific conditional knockout, ChIP (direct target validation), rescue experiments, behavioral testing","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1-2 — ChIP-confirmed direct target with rescue experiment and functional behavioral readout","pmids":["22588081"],"is_preprint":false},{"year":2011,"finding":"Bcl11b directly binds to Foxp3 and IL-10 gene promoters and conserved noncoding sequences; mutation of the Bcl11b binding site in the Foxp3 promoter reduces reporter expression, demonstrating Bcl11b directly activates Foxp3 and IL-10 transcription in T regulatory cells.","method":"ChIP, promoter mutation/reporter assay, conditional knockout","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1-2 — direct binding confirmed by ChIP with functional promoter mutagenesis","pmids":["21875956"],"is_preprint":false},{"year":2011,"finding":"BCL11B structural mutations in T-ALL disrupt zinc finger domain structure required for DNA binding, as revealed by structural homology modeling; missense mutations in zinc finger domains abrogate the protein's DNA-binding capacity.","method":"Structural homology modeling, DNA copy number analysis, sequencing of patient specimens","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 3-4 — structural modeling without direct biochemical validation of mutant DNA binding","pmids":["21878675"],"is_preprint":false},{"year":2018,"finding":"BCL11B homodimerizes through its N-terminal CCHC zinc finger motif; this dimerization is necessary and sufficient for transcriptional regulatory activity, cell cycle arrest induction, and protection against DNA damage-driven apoptosis. The pathogenic N441K dominant-negative mutation acts by forming a nonfunctional dimer with wild-type BCL11B.","method":"FACS-FRET assay, affinity purification/mass spectrometry, CCHC zinc finger mutagenesis, cell cycle analysis, apoptosis assay","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1-2 — domain mapping with mutagenesis plus multiple functional readouts in single rigorous study","pmids":["29203643"],"is_preprint":false},{"year":2016,"finding":"A patient de novo missense mutation p.N441K in BCL11B produces a dominant-negative protein that abrogates wild-type BCL11B's ability to bind DNA, arresting T-cell development and disrupting hematopoietic stem cell migration; this reveals a prethymic role for BCL11B in hematopoietic progenitor migration.","method":"Exome sequencing, functional assays in human HSCs, zebrafish bcl11ba knockout rescue with wild-type vs. mutant human BCL11B","journal":"The New England journal of medicine","confidence":"High","confidence_rationale":"Tier 1-2 — in vivo rescue experiment in zebrafish plus human HSC functional assay","pmids":["27959755"],"is_preprint":false},{"year":2010,"finding":"Bcl11b controls antigen-dependent CD8+ T cell clonal expansion and cytolytic activity; it directly binds the E8I, E8IV, and E8V enhancers (but not E8II/E8III) to maintain optimal CD8 coreceptor expression, and Bcl11b-deficient CD8 T cells show deregulated Plcgamma1 and reduced granzyme B and perforin.","method":"ChIP (enhancer binding), conditional knockout, viral infection model, flow cytometry, cytotoxicity assay","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1-2 — ChIP-confirmed enhancer binding with in vivo functional readouts","pmids":["20660613"],"is_preprint":false},{"year":2011,"finding":"Bcl11b in DP thymocytes controls iNKT cell positive selection by regulating glycolipid self-antigen presentation via control of lysosomal gene expression; Bcl11b-deficient DP thymocytes show enlarged lysosomes, accumulation of glycosphingolipids, and altered expression of lysosomal proteins including cathepsins and Niemann-Pick genes.","method":"Conditional knockout, electron microscopy, flow cytometry, gene expression analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with specific biochemical and cellular phenotype, multiple readouts","pmids":["21444811"],"is_preprint":false},{"year":2013,"finding":"BCL11B functions as a transcriptional repressor in Ewing sarcoma through the NuRD co-repressor complex; it contributes to the EWS/FLI repressed gene signature and represses SPRY1, whose re-expression limits Ewing sarcoma transformation capacity.","method":"ChIP, siRNA knockdown, re-expression experiments, colony formation assay","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2-3 — ChIP and functional rescue, single lab","pmids":["23527175"],"is_preprint":false},{"year":2007,"finding":"Bcl11b-knockdown T-cell lines show apoptosis in S phase with decreased p27 and Bcl-xL due to transcriptional repression, linked to impairment of Sirt1 (a NAD+-dependent deacetylase that associates with Bcl11b); this leads to Claspin cleavage and failure to phosphorylate Chk1, implicating Bcl11b in DNA replication stress response and genomic integrity maintenance.","method":"siRNA knockdown, Sirt1 co-immunoprecipitation, cell cycle analysis, Chk1 phosphorylation assay, UV irradiation of Bcl11b-/- thymocytes","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2-3 — co-IP with functional kinase readout, single lab","pmids":["17369851"],"is_preprint":false},{"year":2015,"finding":"Bcl11b directly represses Id2 in early T-lineage cells to prevent innate lymphoid/NK fate adoption, but in ILC2s Bcl11b and Id2 are co-expressed; Bcl11b binding shows cell-type-specific genomic occupancy patterns and controls entirely different target gene sets in pro-T cells vs. ILC2s, and carries cell-type-specific post-translational modifications and protein complex compositions.","method":"ChIP-seq, conditional knockout in both lineages, mass spectrometry of protein complexes, reporter assays","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1-2 — genome-wide ChIP-seq plus MS-characterized complexes in two cell types with KO validation","pmids":["31653691"],"is_preprint":false},{"year":2015,"finding":"Bcl11b acts directly upstream of Gfi1 to maintain its expression in mature ILC2s; in the absence of Bcl11b, Gata3 and IL-33 receptor (Il1rl1) are downregulated, and Bcl11b independently represses the ILC3 transcription factor Ahr to maintain ILC2 lineage fidelity.","method":"Conditional Bcl11b knockout in ILC2s, gene expression profiling, ChIP (direct regulation of Gfi1 and Ahr), cytokine assays","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 2 — ChIP-confirmed direct targets with conditional KO and functional cytokine readouts","pmids":["26231117"],"is_preprint":false},{"year":2017,"finding":"Bcl11b primes the ThPOK and Runx3 lineage-specifying genes prior to TCR selection, with initial Thpok repression dependent on the last zinc finger motif of Bcl11b (distinct from the zinc finger required for T-lineage commitment), thereby coupling TCR MHC-restriction signals to the transcriptional program for CD4/CD8 lineage choice.","method":"Bcl11b conditional knockout, zinc finger point mutant (Bcl11b F/S826G), reporter assays, TCR-transgenic rescue","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — domain-specific zinc finger mutant with epistasis and TCR-transgenic rescue","pmids":["28951542"],"is_preprint":false},{"year":2018,"finding":"Bcl11b binds GATA3 through protein-protein interaction and co-localizes with GATA3 at cis-regulatory elements in Th2 cells; Bcl11b-deficient Th2 cells show GATA3-dependent upregulation of IL-4, IL-5, and IL-13, indicating Bcl11b limits GATA3-mediated type 2 cytokine gene expression.","method":"Co-IP (protein-protein interaction), ChIP-seq, RNA-seq, conditional knockout","journal":"The Journal of experimental medicine","confidence":"High","confidence_rationale":"Tier 1-2 — direct interaction confirmed by co-IP with genome-wide co-occupancy and KO functional readout","pmids":["29514917"],"is_preprint":false},{"year":2018,"finding":"Bcl11b maintains chromatin accessibility at Th2-cytokine promoters and locus-control regions, binds the Il4 HS IV silencer to reduce its accessibility, binds GATA3 intronic/downstream noncoding sites to sustain Gata3 expression, and binds/deactivates upstream Runx3 enhancers to restrict Runx3 expression and its repressive activity at Il4 HS IV.","method":"ATAC-seq, ChIP, conditional knockout, helminth infection model","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 — ATAC-seq plus ChIP with in vivo functional model","pmids":["29700302"],"is_preprint":false},{"year":2011,"finding":"Genome-wide ChIP-seq in striatal cells identifies Bcl11b binding sites predominantly within 10 kb of transcription start sites; integration with expression profiling identifies 248 direct Bcl11b targets including components of the BDNF/neurotrophin signaling pathway, and reveals consensus DNA-binding motifs for Bcl11b.","method":"ChIP-seq, microarray expression profiling, Bcl11b overexpression","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 1-2 — genome-wide ChIP-seq with expression integration, single lab","pmids":["21912641"],"is_preprint":false},{"year":2009,"finding":"Ctip2/BCL11B is required for ameloblast formation in tooth development; it controls expression of amelogenin, ameloblastin, enamelin, Msx2, and epiprofin, and regulates ameloblast morphology, polarization, and adhesion properties.","method":"Conditional and germline Ctip2 knockout, immunohistochemistry, in situ hybridization, gene expression analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — clean KO with specific molecular and cellular readouts in defined developmental context","pmids":["19251658"],"is_preprint":false},{"year":2012,"finding":"Ctip2 controls keratinocyte proliferation and differentiation by directly and positively regulating EGFR transcription in proliferating cells and Notch1 transcription in differentiating cells; EGFR signaling downregulates Ctip2 mRNA, while high calcium signaling triggers Ctip2 SUMOylation, ubiquitination and proteasomal degradation, forming a negative feedback loop.","method":"ChIP (EGFR and Notch1 promoter occupancy), knockdown/overexpression, Western blot, promoter reporter assay","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1-2 — ChIP-confirmed direct transcriptional targets plus biochemical characterization of PTM-driven degradation","pmids":["23015591"],"is_preprint":false},{"year":2012,"finding":"Ctip2 is recruited to promoters of sphingolipid biosynthesis genes in developing skin and regulates epidermal ceramide and sphingomyelin composition; loss of Ctip2 alters major epidermal lipid species as measured by targeted lipidomics.","method":"ChIP, targeted lipidomics by mass spectrometry, Ctip2 knockout mouse","journal":"The Journal of investigative dermatology","confidence":"Medium","confidence_rationale":"Tier 2-3 — ChIP confirmed recruitment, single lab with lipidomics readout","pmids":["23096701"],"is_preprint":false},{"year":2012,"finding":"Keratinocytic Ctip2 directly represses TSLP transcription as demonstrated by ChIP; Ctip2 deletion leads to TSLP upregulation, triggering atopic dermatitis-like skin inflammation with Th2-type cytokine responses and immune cell infiltration.","method":"Conditional epidermal Ctip2 knockout, ChIP (TSLP promoter), histology, cytokine profiling","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2-3 — ChIP-confirmed direct repression with in vivo inflammatory phenotype, single lab","pmids":["23284675"],"is_preprint":false},{"year":2015,"finding":"Bcl11b acts as a SWI/SNF complex subunit and regulates intestinal adenoma development; Bcl11b attenuation in Lgr5+ crypt base columnar cells increases expression of β-catenin target genes (c-Myc, cyclin D1), and BCL11B introduction in human cell lines downregulates β-catenin target gene transcription.","method":"Bcl11b heterozygous mice crossed to ApcMin/+, reporter assays, gene expression analysis in intestinal stem cells","journal":"Carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 2-3 — genetic model with reporter assay, single lab","pmids":["25827435"],"is_preprint":false},{"year":2019,"finding":"HIV-1 Vpr promotes proteasomal degradation of CTIP2 in microglial cells and CD4+ T cells via association with the Cul4A-DDB1-DCAF1 ubiquitin ligase complex, targeting CTIP2 at the latent HIV-1 promoter where it is associated with heterochromatin-promoting enzymes, thereby reactivating HIV-1 expression.","method":"Co-IP, proteasome inhibitor treatment, ChIP, siRNA/dominant-negative experiments in microglial HIV-1 latency model","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2-3 — co-IP plus proteasome inhibitor rescue with ChIP, single lab","pmids":["31511615"],"is_preprint":false},{"year":2019,"finding":"Bcl11b determines odorant receptor class choice in olfactory sensory neurons: loss-of-function biases OR choice toward class I (default), while gain-of-function biases toward class II; Bcl11b promotes class II OR expression by suppressing the activity of the J-element, a class I-OR enhancer.","method":"OSN-specific conditional Bcl11b knockout and overexpression, single-cell analysis, enhancer reporter assays, innate olfactory behavior assays","journal":"Communications biology","confidence":"High","confidence_rationale":"Tier 1-2 — bidirectional gain/loss-of-function with enhancer mechanism and behavioral readout","pmids":["31396576"],"is_preprint":false},{"year":2019,"finding":"CTIP2-deficient human medium spiny neurons derived from hPSCs show substantial reduction in phosphorylation of DARPP32 and GluR1 (two PKA targets), implicating CTIP2 in regulating PKA signaling in striatal neurons; transcriptomic analysis confirms CTIP2 targets are at the core of cAMP-Ca2+ signal integration in the PKA pathway.","method":"CTIP2-deficient human PSC-derived MSNs, phosphoprotein analysis, transcriptomics, HD mouse model comparison","journal":"Stem cell reports","confidence":"Medium","confidence_rationale":"Tier 2-3 — KO-based phosphoproteomic readout, single lab, human and mouse models","pmids":["31447328"],"is_preprint":false},{"year":2024,"finding":"BCL11B succeeds PU.1 in a transcription factor 'relay' to maintain mSWI/SNF chromatin remodeling complex occupancy together with RUNX1 at T effector loci after PU.1 silencing during T lineage commitment, thereby poising the T cell effector chromatin landscape early in development.","method":"ChIP-seq, ATAC-seq, conditional knockout of PU.1 and BCL11B, mSWI/SNF co-immunoprecipitation","journal":"Nature immunology","confidence":"High","confidence_rationale":"Tier 1-2 — genome-wide ChIP-seq with co-IP and conditional KO, mechanistic relay model with multiple orthogonal methods","pmids":["38632339"],"is_preprint":false}],"current_model":"BCL11B/CTIP2 is a zinc finger transcription factor that functions as both a transcriptional repressor and activator depending on cell context: it recruits chromatin-modifying enzyme complexes (NuRD, HDAC1/2, SUV39H1, LSD1) to silence target genes including HIV-1 and p21WAF1; sequesters and inhibits P-TEFb kinase activity via interaction with the 7SK/HEXIM1 complex; homodimerizes through its N-terminal CCHC zinc finger domain (required for transcriptional activity); directly binds DNA at specific motifs and also interacts with partner transcription factors (GATA3, COUP-TF, RUNX1) to regulate distinct gene programs; recruits mSWI/SNF chromatin remodeling complexes to poise effector T cell loci; and acts as a master transcriptional regulator of T lineage commitment, ILC2 identity, cortical/striatal neuron differentiation, and epidermal homeostasis by controlling lineage-specific gene networks through context-dependent post-translational modifications and protein complex compositions."},"narrative":{"teleology":[{"year":2003,"claim":"Early work established that BCL11B is essential for T-cell development and identified its role as a heterochromatin organizer: Bcl11b knockout mice revealed a block at the DN stage with failed V(D)J recombination, while domain mapping showed BCL11B sequesters HIV-1 Tat into HP1α-containing heterochromatic structures to silence viral transcription.","evidence":"Bcl11b germline knockout with recombination PCR and flow cytometry; co-IP/confocal with deletion mutants in transfected cells","pmids":["12717433","12692243"],"confidence":"High","gaps":["Mechanism by which BCL11B controls V(D)J recombination accessibility was not defined","Whether HP1α interaction is required for endogenous gene silencing beyond HIV-1 was untested"]},{"year":2007,"claim":"The chromatin-modifying machinery through which BCL11B silences genes was delineated: BCL11B recruits HDAC1/2 and SUV39H1 to the HIV-1 promoter to establish H3 deacetylation and H3K9 trimethylation, and a parallel study linked BCL11B to Sirt1 and the DNA replication stress response through Chk1 phosphorylation.","evidence":"ChIP, co-IP, and pharmacological inhibition in microglial cells; siRNA knockdown with Sirt1 co-IP and Chk1 phosphorylation assay in T-cell lines","pmids":["17245431","17369851"],"confidence":"High","gaps":["Whether HDAC1/2 and SUV39H1 are recruited as a single complex or sequentially was unresolved","Sirt1–BCL11B interaction lacked independent replication"]},{"year":2006,"claim":"BCL11B was shown to physically associate with the NuRD complex through direct binding to RbAp46/48, establishing NuRD as a major effector of BCL11B-mediated transcriptional repression at endogenous gene promoters such as p57KIP2.","evidence":"Co-IP, in vitro pulldown, and ChIP co-occupancy at the p57KIP2 promoter in neuroblastoma cells","pmids":["16950772"],"confidence":"High","gaps":["Full stoichiometry and subunit composition of the BCL11B–NuRD complex were not determined","Whether NuRD mediates all BCL11B repressive functions or only a subset was unclear"]},{"year":2008,"claim":"BCL11B's roles in neuronal fate specification were established: it acts downstream of Fezf2 to direct subcortical axon projections of corticospinal neurons, and is required for medium spiny neuron differentiation and striatal patch organization.","evidence":"Epistasis analysis with in utero electroporation and axon tracing in Fezf2-KO rescue; Ctip2 knockout with immunohistochemistry and in situ hybridization for MSN markers","pmids":["18678899","18199763"],"confidence":"High","gaps":["Direct transcriptional targets mediating axon guidance decisions were not identified","Whether BCL11B acts through NuRD or distinct complexes in neurons was unknown"]},{"year":2010,"claim":"BCL11B was identified as the gatekeeper of T-cell versus NK-cell identity: its deletion in committed T cells reprograms them into functional NK-like cells, and it acts at the DN2-to-DN3 transition to repress NK-associated and stem cell genes, while also directly binding CD8 enhancers to control effector T-cell function.","evidence":"Conditional and germline Bcl11b knockouts with gene expression profiling, cytotoxicity assays, in vivo tumor and viral infection models, ChIP at CD8 enhancers","pmids":["20595614","20538915","20660613"],"confidence":"High","gaps":["Whether T-to-NK reprogramming occurs through a multipotent intermediate was unresolved","The complete set of BCL11B-repressed NK genes was not defined genome-wide"]},{"year":2011,"claim":"BCL11B's direct transcriptional targets were expanded to include Foxp3 and IL-10 in Tregs, lysosomal genes controlling iNKT cell selection, and neurotrophin pathway components in the striatum, while LSD1 was identified as an additional BCL11B-cooperating chromatin modifier at the HIV-1 promoter.","evidence":"ChIP with promoter mutagenesis in Tregs; conditional KO with electron microscopy and lipid analysis for iNKT; ChIP-seq with expression profiling in striatal cells; ChIP/co-IP for LSD1 at HIV-1 promoter","pmids":["21875956","21444811","21912641","22067449"],"confidence":"High","gaps":["How BCL11B switches from repressor to activator at Foxp3 was mechanistically unexplained","LSD1 cooperation was characterized at HIV-1 but not validated at endogenous targets"]},{"year":2012,"claim":"BCL11B's functions were extended to epithelial biology and hippocampal neurogenesis: it directly activates EGFR and Notch1 in keratinocytes, regulates sphingolipid biosynthesis genes in skin, represses TSLP to prevent atopic dermatitis, and controls dentate gyrus neurogenesis through Desmoplakin as a direct target.","evidence":"ChIP at EGFR/Notch1/TSLP/sphingolipid promoters; conditional epidermal and forebrain KO models; rescue of neurogenesis by Desmoplakin re-expression; lipidomics","pmids":["23015591","23096701","23284675","22588081"],"confidence":"High","gaps":["How calcium-induced SUMOylation and proteasomal degradation of BCL11B are coordinated in vivo was not fully resolved","Whether sphingolipid changes are a primary or secondary consequence of BCL11B loss was unclear"]},{"year":2013,"claim":"A kinase-independent function was revealed: BCL11B directly interacts with HEXIM1 and the 7SK snRNP to sequester P-TEFb, repressing CDK9 kinase activity at target promoters including MYH7 in cardiomyopathic hearts, while a distal enhancer (~850 kb downstream) was identified as the T-cell-specific regulatory element that activates BCL11B expression through chromatin looping.","evidence":"In vitro CDK9 kinase assay, co-purification and ChIP in cardiac cells; BAC transgenics and chromatin looping assays for enhancer","pmids":["23852730","23741008"],"confidence":"High","gaps":["Whether P-TEFb sequestration is a general mechanism at all BCL11B-repressed promoters was untested","Factors controlling enhancer–promoter loop formation beyond TCF-1 were not fully defined"]},{"year":2016,"claim":"The upstream regulatory logic activating BCL11B expression during T-cell commitment was decoded: four inputs (TCF-1, GATA-3, Notch, Runx1) converge on the distal enhancer with distinct kinetics—poising, stochastic permissivity, and amplitude control—resolving how BCL11B activation timing is regulated.","evidence":"Bcl11b knock-in fluorescent reporter with single-cell live imaging; systematic genetic deletion of each factor","pmids":["27376470"],"confidence":"High","gaps":["Epigenetic state transitions at the enhancer during each regulatory input were not fully mapped","Whether the same regulatory logic operates in non-T lineages expressing BCL11B was unknown"]},{"year":2016,"claim":"A de novo BCL11B missense mutation (N441K) was shown to cause human immunodeficiency by acting as a dominant-negative that abrogates DNA binding and arrests T-cell development, also revealing a previously unappreciated prethymic role for BCL11B in hematopoietic progenitor migration.","evidence":"Exome sequencing of patient; zebrafish bcl11ba KO rescue with WT versus mutant human BCL11B; human HSC migration assays","pmids":["27959755"],"confidence":"High","gaps":["The molecular mechanism of prethymic migration control was not defined","Whether other BCL11B mutations cause the same syndrome was not yet established"]},{"year":2018,"claim":"BCL11B's oligomeric state was resolved: it homodimerizes through the N-terminal CCHC zinc finger, and this dimerization is necessary for transcriptional activity, cell cycle arrest, and protection from DNA damage; the N441K pathogenic mutation acts by forming nonfunctional dimers with wild-type protein.","evidence":"FACS-FRET, AP-MS, CCHC zinc finger mutagenesis, cell cycle and apoptosis assays","pmids":["29203643"],"confidence":"High","gaps":["Whether BCL11B can also heterodimerize with BCL11A was not addressed","Structural basis of the dimer interface at atomic resolution was lacking"]},{"year":2018,"claim":"BCL11B's interaction with GATA3 was characterized as a direct protein–protein association at co-occupied Th2 cis-regulatory elements, where BCL11B restrains GATA3-driven type 2 cytokine overproduction and maintains chromatin accessibility at cytokine loci while silencing the Il4 HS IV element through Runx3 restriction.","evidence":"Co-IP, ChIP-seq, ATAC-seq, RNA-seq, conditional KO in Th2 cells, helminth infection model","pmids":["29514917","29700302"],"confidence":"High","gaps":["Structural basis of BCL11B–GATA3 interaction was undetermined","Whether this restraining mechanism operates in human Th2-driven disease was untested in vivo"]},{"year":2019,"claim":"Context-dependent BCL11B function was mechanistically explained: ChIP-seq in pro-T cells versus ILC2s showed largely non-overlapping genomic binding, with distinct post-translational modifications and partner complexes in each lineage; simultaneously, BCL11B was shown to determine odorant receptor class choice in olfactory neurons and regulate PKA signaling in human striatal neurons.","evidence":"ChIP-seq and MS of BCL11B complexes in two lineages with conditional KO; OSN-specific KO/overexpression with enhancer reporters; CTIP2-deficient hPSC-derived MSNs with phosphoprotein analysis","pmids":["31653691","31396576","31447328"],"confidence":"High","gaps":["Specific PTMs driving cell-type-specific binding were not fully catalogued","Whether BCL11B directly regulates PKA pathway genes or acts indirectly through DARPP-32 was unclear"]},{"year":2019,"claim":"HIV-1 Vpr was found to counteract BCL11B-mediated latency by targeting CTIP2 for proteasomal degradation via the Cul4A–DDB1–DCAF1 ubiquitin ligase complex, revealing a viral strategy to reactivate latent provirus by eliminating its silencing factor.","evidence":"Co-IP, proteasome inhibitor rescue, ChIP at latent HIV-1 promoter, siRNA/dominant-negative in microglial latency model","pmids":["31511615"],"confidence":"Medium","gaps":["Whether Vpr-mediated BCL11B degradation occurs in primary latently infected CD4+ T cells in vivo was not demonstrated","Quantitative contribution of BCL11B degradation versus other Vpr targets to latency reversal was unresolved"]},{"year":2024,"claim":"BCL11B was shown to participate in a transcription factor relay with PU.1 during T lineage commitment: as PU.1 is silenced, BCL11B together with RUNX1 takes over mSWI/SNF complex recruitment at T effector loci, maintaining chromatin accessibility and poising the effector gene program early in development.","evidence":"ChIP-seq and ATAC-seq with conditional KO of PU.1 and BCL11B; mSWI/SNF co-immunoprecipitation","pmids":["38632339"],"confidence":"High","gaps":["Whether BCL11B is a stable mSWI/SNF subunit or a transient recruiter was not resolved","How BCL11B discriminates between mSWI/SNF-dependent and NuRD-dependent targets at the same developmental stage is unknown"]},{"year":null,"claim":"Key unresolved questions include: the structural basis of BCL11B homodimerization and partner interactions; how post-translational modifications switch BCL11B between activator and repressor modes; and the full spectrum of human disease caused by BCL11B mutations beyond the initial immunodeficiency case.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of BCL11B or its complexes exists","Systematic mapping of PTMs to functional outputs across cell types is lacking","Genotype–phenotype relationships for BCL11B variants in neurodevelopmental and immune disorders are incomplete"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,2,3,5,6,16,25,27,31]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[17,18,20,29]},{"term_id":"GO:0042393","term_label":"histone binding","supporting_discovery_ids":[0,3]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[4,14]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,1,2,3,18]},{"term_id":"GO:0005654","term_label":"nucleoplasm","supporting_discovery_ids":[0,2,29]},{"term_id":"GO:0005694","term_label":"chromosome","supporting_discovery_ids":[1,0]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,2,3,16,25,27,28,31]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[0,3,13,38]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[5,6,7,8,20,21,26]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[9,10,30,36]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[17,19,22]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[8,18,23]}],"complexes":["NuRD","7SK/HEXIM1/P-TEFb snRNP","mSWI/SNF"],"partners":["HDAC1","HDAC2","SUV39H1","HEXIM1","GATA3","RUNX1","HP1A","RBBP7"],"other_free_text":[]},"mechanistic_narrative":"BCL11B (CTIP2) is a C2H2/CCHC zinc finger transcription factor that serves as a master regulator of cell identity across multiple lineages, including T lymphocytes, innate lymphoid cells, cortical and striatal neurons, olfactory sensory neurons, keratinocytes, and ameloblasts. It functions as both a transcriptional repressor and activator in a context-dependent manner: as a repressor, it recruits the NuRD chromatin-remodeling complex, HDAC1/2, SUV39H1, and LSD1 to silence targets such as HIV-1, p21WAF1, TSLP, and Id2 through heterochromatin establishment [PMID:17245431, PMID:16950772, PMID:19581932]; as an activator, it directly binds and sustains expression of lineage-critical genes including Foxp3, Gfi1, EGFR, and Notch1, and cooperates with RUNX1 to recruit mSWI/SNF complexes to poise T cell effector loci [PMID:21875956, PMID:26231117, PMID:38632339]. BCL11B homodimerizes through its N-terminal CCHC zinc finger—a requirement for transcriptional activity—and its genomic occupancy, post-translational modifications, and protein complex composition differ between cell types, enabling it to control distinct gene programs in pro-T cells versus ILC2s [PMID:29203643, PMID:31653691]. De novo BCL11B mutations cause human immunodeficiency with arrested T-cell development and impaired hematopoietic progenitor migration [PMID:27959755]."},"prefetch_data":{"uniprot":{"accession":"Q9C0K0","full_name":"B-cell lymphoma/leukemia 11B","aliases":["B-cell CLL/lymphoma 11B","COUP-TF-interacting protein 2","Radiation-induced tumor suppressor gene 1 protein","hRit1"],"length_aa":894,"mass_kda":95.5,"function":"Key regulator of both differentiation and survival of T-lymphocytes during thymocyte development in mammals. Essential in controlling the responsiveness of hematopoietic stem cells to chemotactic signals by modulating the expression of the receptors CCR7 and CCR9, which direct the movement of progenitor cells from the bone marrow to the thymus (PubMed:27959755). Is a regulator of IL2 promoter and enhances IL2 expression in activated CD4(+) T-lymphocytes (PubMed:16809611). Tumor-suppressor that represses transcription through direct, TFCOUP2-independent binding to a GC-rich response element (By similarity). May also function in the P53-signaling pathway (By similarity)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q9C0K0/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/BCL11B","classification":"Not Classified","n_dependent_lines":18,"n_total_lines":1208,"dependency_fraction":0.014900662251655629},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/BCL11B","total_profiled":1310},"omim":[{"mim_id":"618092","title":"INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA","url":"https://www.omim.org/entry/618092"},{"mim_id":"617800","title":"MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19","url":"https://www.omim.org/entry/617800"},{"mim_id":"617237","title":"IMMUNODEFICIENCY 49, SEVERE COMBINED; IMD49","url":"https://www.omim.org/entry/617237"},{"mim_id":"607414","title":"FEZ FAMILY ZINC FINGER PROTEIN 2; FEZF2","url":"https://www.omim.org/entry/607414"},{"mim_id":"606990","title":"COATOMER PROTEIN COMPLEX, SUBUNIT BETA-2; COPB2","url":"https://www.omim.org/entry/606990"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Nucleoli fibrillar center","reliability":"Additional"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":12.4},{"tissue":"lymphoid tissue","ntpm":34.1},{"tissue":"skin 1","ntpm":14.2}],"url":"https://www.proteinatlas.org/search/BCL11B"},"hgnc":{"alias_symbol":["CTIP-2","CTIP2","hRIT1-alpha","SMARCM2"],"prev_symbol":["ZNF856B"]},"alphafold":{"accession":"Q9C0K0","domains":[{"cath_id":"3.30.160.60","chopping":"426-477","consensus_level":"high","plddt":86.2194,"start":426,"end":477},{"cath_id":"3.30.160","chopping":"854-887","consensus_level":"medium","plddt":74.2174,"start":854,"end":887}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9C0K0","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9C0K0-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9C0K0-F1-predicted_aligned_error_v6.png","plddt_mean":50.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=BCL11B","jax_strain_url":"https://www.jax.org/strain/search?query=BCL11B"},"sequence":{"accession":"Q9C0K0","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9C0K0.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9C0K0/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9C0K0"}},"corpus_meta":[{"pmid":"20595614","id":"PMC_20595614","title":"An early T cell lineage commitment checkpoint dependent on the transcription factor Bcl11b.","date":"2010","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/20595614","citation_count":311,"is_preprint":false},{"pmid":"12717433","id":"PMC_12717433","title":"Bcl11b is required for differentiation and survival of alphabeta T lymphocytes.","date":"2003","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12717433","citation_count":300,"is_preprint":false},{"pmid":"17245431","id":"PMC_17245431","title":"Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing.","date":"2007","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/17245431","citation_count":296,"is_preprint":false},{"pmid":"20538915","id":"PMC_20538915","title":"Reprogramming of T cells to natural killer-like cells upon Bcl11b deletion.","date":"2010","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/20538915","citation_count":290,"is_preprint":false},{"pmid":"18678899","id":"PMC_18678899","title":"The Fezf2-Ctip2 genetic pathway regulates the fate choice of subcortical projection neurons in the developing cerebral cortex.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18678899","citation_count":279,"is_preprint":false},{"pmid":"18199763","id":"PMC_18199763","title":"Ctip2 controls the differentiation of medium spiny neurons and the establishment of the cellular architecture of the striatum.","date":"2008","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18199763","citation_count":262,"is_preprint":false},{"pmid":"21878675","id":"PMC_21878675","title":"The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia.","date":"2011","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/21878675","citation_count":161,"is_preprint":false},{"pmid":"34103329","id":"PMC_34103329","title":"Enhancer Hijacking Drives Oncogenic BCL11B Expression in Lineage-Ambiguous Stem Cell Leukemia.","date":"2021","source":"Cancer discovery","url":"https://pubmed.ncbi.nlm.nih.gov/34103329","citation_count":156,"is_preprint":false},{"pmid":"26231117","id":"PMC_26231117","title":"Transcription Factor Bcl11b Controls Identity and Function of Mature Type 2 Innate Lymphoid Cells.","date":"2015","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/26231117","citation_count":143,"is_preprint":false},{"pmid":"25964370","id":"PMC_25964370","title":"Bcl11b is essential for group 2 innate lymphoid cell development.","date":"2015","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25964370","citation_count":137,"is_preprint":false},{"pmid":"25964371","id":"PMC_25964371","title":"The transcription factor Bcl11b is specifically expressed in group 2 innate lymphoid cells and is essential for their development.","date":"2015","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25964371","citation_count":134,"is_preprint":false},{"pmid":"15465497","id":"PMC_15465497","title":"CTIP1 and CTIP2 are differentially expressed during mouse embryogenesis.","date":"2004","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/15465497","citation_count":132,"is_preprint":false},{"pmid":"17998389","id":"PMC_17998389","title":"BCL11B is required for positive selection and survival of double-positive thymocytes.","date":"2007","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/17998389","citation_count":117,"is_preprint":false},{"pmid":"27376470","id":"PMC_27376470","title":"Asynchronous combinatorial action of four regulatory factors activates Bcl11b for T cell commitment.","date":"2016","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27376470","citation_count":111,"is_preprint":false},{"pmid":"23741008","id":"PMC_23741008","title":"A far downstream enhancer for murine Bcl11b controls its T-cell specific expression.","date":"2013","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/23741008","citation_count":105,"is_preprint":false},{"pmid":"12565905","id":"PMC_12565905","title":"Homozygous deletions and point mutations of the Rit1/Bcl11b gene in gamma-ray induced mouse thymic lymphomas.","date":"2003","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12565905","citation_count":104,"is_preprint":false},{"pmid":"27959755","id":"PMC_27959755","title":"Multisystem Anomalies in Severe Combined Immunodeficiency with Mutant BCL11B.","date":"2016","source":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27959755","citation_count":102,"is_preprint":false},{"pmid":"19581932","id":"PMC_19581932","title":"p21(WAF1) gene promoter is epigenetically silenced by CTIP2 and SUV39H1.","date":"2009","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/19581932","citation_count":101,"is_preprint":false},{"pmid":"22588081","id":"PMC_22588081","title":"A dual function of Bcl11b/Ctip2 in hippocampal neurogenesis.","date":"2012","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/22588081","citation_count":99,"is_preprint":false},{"pmid":"20969590","id":"PMC_20969590","title":"Critical roles of Bcl11b in T-cell development and maintenance of T-cell identity.","date":"2010","source":"Immunological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/20969590","citation_count":93,"is_preprint":false},{"pmid":"28041896","id":"PMC_28041896","title":"A Quiescent Bcl11b High Stem Cell Population Is Required for Maintenance of the Mammary Gland.","date":"2016","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/28041896","citation_count":92,"is_preprint":false},{"pmid":"29985992","id":"PMC_29985992","title":"BCL11B mutations in patients affected by a neurodevelopmental disorder with reduced type 2 innate lymphoid cells.","date":"2018","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/29985992","citation_count":92,"is_preprint":false},{"pmid":"16950772","id":"PMC_16950772","title":"CTIP2 associates with the NuRD complex on the promoter of p57KIP2, a newly identified CTIP2 target gene.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/16950772","citation_count":86,"is_preprint":false},{"pmid":"25128552","id":"PMC_25128552","title":"The multifaceted roles of Bcl11b in thymic and peripheral T cells: impact on immune diseases.","date":"2014","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/25128552","citation_count":75,"is_preprint":false},{"pmid":"23852730","id":"PMC_23852730","title":"CTIP2 is a negative regulator of P-TEFb.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23852730","citation_count":75,"is_preprint":false},{"pmid":"22068335","id":"PMC_22068335","title":"Common genetic variation in the 3'-BCL11B gene desert is associated with carotid-femoral pulse wave velocity and excess cardiovascular disease risk: the AortaGen Consortium.","date":"2011","source":"Circulation. Cardiovascular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22068335","citation_count":72,"is_preprint":false},{"pmid":"21875956","id":"PMC_21875956","title":"Critical role of Bcl11b in suppressor function of T regulatory cells and prevention of inflammatory bowel disease.","date":"2011","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21875956","citation_count":72,"is_preprint":false},{"pmid":"33876209","id":"PMC_33876209","title":"14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia.","date":"2021","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/33876209","citation_count":71,"is_preprint":false},{"pmid":"33712472","id":"PMC_33712472","title":"The transcription factor Bcl11b promotes both canonical and adaptive NK cell differentiation.","date":"2021","source":"Science immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33712472","citation_count":70,"is_preprint":false},{"pmid":"23175820","id":"PMC_23175820","title":"The CB(1) cannabinoid receptor drives corticospinal motor neuron differentiation through the Ctip2/Satb2 transcriptional regulation axis.","date":"2012","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/23175820","citation_count":68,"is_preprint":false},{"pmid":"17173069","id":"PMC_17173069","title":"Inhibition of BCL11B expression leads to apoptosis of malignant but not normal mature T cells.","date":"2006","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17173069","citation_count":68,"is_preprint":false},{"pmid":"22067449","id":"PMC_22067449","title":"LSD1 cooperates with CTIP2 to promote HIV-1 transcriptional silencing.","date":"2011","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/22067449","citation_count":66,"is_preprint":false},{"pmid":"12692243","id":"PMC_12692243","title":"Recruitment of Tat to heterochromatin protein HP1 via interaction with CTIP2 inhibits human immunodeficiency virus type 1 replication in microglial cells.","date":"2003","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/12692243","citation_count":65,"is_preprint":false},{"pmid":"24739528","id":"PMC_24739528","title":"Unc5C and DCC act downstream of Ctip2 and Satb2 and contribute to corpus callosum formation.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/24739528","citation_count":59,"is_preprint":false},{"pmid":"28424591","id":"PMC_28424591","title":"Bcl11b-A Critical Neurodevelopmental Transcription Factor-Roles in Health and Disease.","date":"2017","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/28424591","citation_count":58,"is_preprint":false},{"pmid":"31653691","id":"PMC_31653691","title":"Cell type-specific actions of Bcl11b in early T-lineage and group 2 innate lymphoid cells.","date":"2020","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31653691","citation_count":56,"is_preprint":false},{"pmid":"22450536","id":"PMC_22450536","title":"Role of the transcription factor Bcl11b in development and lymphomagenesis.","date":"2012","source":"Proceedings of the Japan Academy. Series B, Physical and biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/22450536","citation_count":55,"is_preprint":false},{"pmid":"19251658","id":"PMC_19251658","title":"Ctip2/Bcl11b controls ameloblast formation during mammalian odontogenesis.","date":"2009","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/19251658","citation_count":54,"is_preprint":false},{"pmid":"21752992","id":"PMC_21752992","title":"Bcl11b/Ctip2 controls the differentiation of vomeronasal sensory neurons in mice.","date":"2011","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/21752992","citation_count":54,"is_preprint":false},{"pmid":"28232744","id":"PMC_28232744","title":"The T-ALL related gene BCL11B regulates the initial stages of human T-cell differentiation.","date":"2017","source":"Leukemia","url":"https://pubmed.ncbi.nlm.nih.gov/28232744","citation_count":52,"is_preprint":false},{"pmid":"20660613","id":"PMC_20660613","title":"Antigen-specific clonal expansion and cytolytic effector function of CD8+ T lymphocytes depend on the transcription factor Bcl11b.","date":"2010","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20660613","citation_count":51,"is_preprint":false},{"pmid":"22383956","id":"PMC_22383956","title":"Delayed cutaneous wound healing and aberrant expression of hair follicle stem cell markers in mice selectively lacking Ctip2 in epidermis.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22383956","citation_count":50,"is_preprint":false},{"pmid":"21912641","id":"PMC_21912641","title":"Genome-wide identification of Bcl11b gene targets reveals role in brain-derived neurotrophic factor signaling.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21912641","citation_count":49,"is_preprint":false},{"pmid":"28951542","id":"PMC_28951542","title":"Priming of lineage-specifying genes by Bcl11b is required for lineage choice in post-selection thymocytes.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28951542","citation_count":48,"is_preprint":false},{"pmid":"24623795","id":"PMC_24623795","title":"HMGA1 recruits CTIP2-repressed P-TEFb to the HIV-1 and cellular target promoters.","date":"2014","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/24623795","citation_count":47,"is_preprint":false},{"pmid":"17306224","id":"PMC_17306224","title":"Haploinsufficiency of Bcl11b for suppression of lymphomagenesis and thymocyte development.","date":"2007","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17306224","citation_count":47,"is_preprint":false},{"pmid":"29514917","id":"PMC_29514917","title":"Bcl11b, a novel GATA3-interacting protein, suppresses Th1 while limiting Th2 cell differentiation.","date":"2018","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29514917","citation_count":46,"is_preprint":false},{"pmid":"12661009","id":"PMC_12661009","title":"Activation of HOX11L2 by juxtaposition with 3'-BCL11B in an acute lymphoblastic leukemia cell line (HPB-ALL) with t(5;14)(q35;q32.2).","date":"2003","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/12661009","citation_count":46,"is_preprint":false},{"pmid":"21060114","id":"PMC_21060114","title":"The corticofugal neuron-associated genes ROBO1, SRGAP1, and CTIP2 exhibit an anterior to posterior gradient of expression in early fetal human neocortex development.","date":"2010","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/21060114","citation_count":44,"is_preprint":false},{"pmid":"28794504","id":"PMC_28794504","title":"Promoter hypermethylation of BCL11B gene correlates with downregulation of gene transcription in ankylosing spondylitis patients.","date":"2017","source":"Genes and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/28794504","citation_count":42,"is_preprint":false},{"pmid":"23211040","id":"PMC_23211040","title":"The role of BCL11B in hematological malignancy.","date":"2012","source":"Experimental hematology & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/23211040","citation_count":41,"is_preprint":false},{"pmid":"21444811","id":"PMC_21444811","title":"Transcription factor Bcl11b controls selection of invariant natural killer T-cells by regulating glycolipid presentation in double-positive thymocytes.","date":"2011","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21444811","citation_count":41,"is_preprint":false},{"pmid":"16926283","id":"PMC_16926283","title":"HOX11L2/TLX3 is transcriptionally activated through T-cell regulatory elements downstream of BCL11B as a result of the t(5;14)(q35;q32).","date":"2006","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/16926283","citation_count":41,"is_preprint":false},{"pmid":"17369851","id":"PMC_17369851","title":"Lack of Bcl11b tumor suppressor results in vulnerability to DNA replication stress and damages.","date":"2007","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/17369851","citation_count":40,"is_preprint":false},{"pmid":"23527175","id":"PMC_23527175","title":"BCL11B is up-regulated by EWS/FLI and contributes to the transformed phenotype in Ewing sarcoma.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23527175","citation_count":38,"is_preprint":false},{"pmid":"23284675","id":"PMC_23284675","title":"Selective ablation of Ctip2/Bcl11b in epidermal keratinocytes triggers atopic dermatitis-like skin inflammatory responses in adult mice.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23284675","citation_count":35,"is_preprint":false},{"pmid":"14754877","id":"PMC_14754877","title":"Involvement of V(D)J recombinase in the generation of intragenic deletions in the Rit1/Bcl11b tumor suppressor gene in gamma-ray-induced thymic lymphomas and in normal thymus of the mouse.","date":"2004","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/14754877","citation_count":35,"is_preprint":false},{"pmid":"29700302","id":"PMC_29700302","title":"Bcl11b is essential for licensing Th2 differentiation during helminth infection and allergic asthma.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29700302","citation_count":33,"is_preprint":false},{"pmid":"26915960","id":"PMC_26915960","title":"Structure-function integrity of the adult hippocampus depends on the transcription factor Bcl11b/Ctip2.","date":"2016","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/26915960","citation_count":32,"is_preprint":false},{"pmid":"23015591","id":"PMC_23015591","title":"Ctip2 is a dynamic regulator of epidermal proliferation and differentiation by integrating EGFR and Notch signaling.","date":"2012","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/23015591","citation_count":32,"is_preprint":false},{"pmid":"32255245","id":"PMC_32255245","title":"Distinct Notch1 and BCL11B requirements mediate human γδ/αβ T cell development.","date":"2020","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/32255245","citation_count":31,"is_preprint":false},{"pmid":"17631058","id":"PMC_17631058","title":"Expression of COUP-TF-interacting protein 2 (CTIP2) in mouse skin during development and in adulthood.","date":"2007","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/17631058","citation_count":31,"is_preprint":false},{"pmid":"31347296","id":"PMC_31347296","title":"A De Novo heterozygous frameshift mutation identified in BCL11B causes neurodevelopmental disorder by whole exome sequencing.","date":"2019","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31347296","citation_count":31,"is_preprint":false},{"pmid":"31396576","id":"PMC_31396576","title":"Bcl11b controls odorant receptor class choice in mice.","date":"2019","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/31396576","citation_count":29,"is_preprint":false},{"pmid":"31457080","id":"PMC_31457080","title":"Bcl11b prevents fatal autoimmunity by promoting Treg cell program and constraining innate lineages in Treg cells.","date":"2019","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/31457080","citation_count":29,"is_preprint":false},{"pmid":"21756541","id":"PMC_21756541","title":"Down regulation of BCL11B expression inhibits proliferation and induces apoptosis in malignant T cells by BCL11B-935-siRNA.","date":"2011","source":"Hematology (Amsterdam, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/21756541","citation_count":29,"is_preprint":false},{"pmid":"29203643","id":"PMC_29203643","title":"The N-Terminal CCHC Zinc Finger Motif Mediates Homodimerization of Transcription Factor BCL11B.","date":"2018","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/29203643","citation_count":28,"is_preprint":false},{"pmid":"31511615","id":"PMC_31511615","title":"HIV-1 Vpr mediates the depletion of the cellular repressor CTIP2 to counteract viral gene silencing.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31511615","citation_count":27,"is_preprint":false},{"pmid":"19399189","id":"PMC_19399189","title":"CTIP2 expression in human head and neck squamous cell carcinoma is linked to poorly differentiated tumor status.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19399189","citation_count":27,"is_preprint":false},{"pmid":"36075976","id":"PMC_36075976","title":"Comparative roadmaps of reprogramming and oncogenic transformation identify Bcl11b and Atoh8 as broad regulators of cellular plasticity.","date":"2022","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/36075976","citation_count":26,"is_preprint":false},{"pmid":"22629441","id":"PMC_22629441","title":"BCL11B regulates epithelial proliferation and asymmetric development of the mouse mandibular incisor.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22629441","citation_count":26,"is_preprint":false},{"pmid":"26698402","id":"PMC_26698402","title":"BCL11B/CTIP2 is highly expressed in GABAergic interneurons of the mouse somatosensory cortex.","date":"2015","source":"Journal of chemical neuroanatomy","url":"https://pubmed.ncbi.nlm.nih.gov/26698402","citation_count":26,"is_preprint":false},{"pmid":"34963132","id":"PMC_34963132","title":"Transcription factors Bcl11a and Bcl11b are required for the production and differentiation of cortical projection neurons.","date":"2022","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/34963132","citation_count":25,"is_preprint":false},{"pmid":"28652615","id":"PMC_28652615","title":"Gga-miR-219b targeting BCL11B suppresses proliferation, migration and invasion of Marek's disease tumor cell MSB1.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28652615","citation_count":25,"is_preprint":false},{"pmid":"33194885","id":"PMC_33194885","title":"Mutant BCL11B in a Patient With a Neurodevelopmental Disorder and T-Cell Abnormalities.","date":"2020","source":"Frontiers in pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/33194885","citation_count":25,"is_preprint":false},{"pmid":"20824091","id":"PMC_20824091","title":"Increased expression of bcl11b leads to chemoresistance accompanied by G1 accumulation.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20824091","citation_count":25,"is_preprint":false},{"pmid":"27725726","id":"PMC_27725726","title":"HIC1 controls cellular- and HIV-1- gene transcription via interactions with CTIP2 and HMGA1.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27725726","citation_count":25,"is_preprint":false},{"pmid":"23096701","id":"PMC_23096701","title":"Transcription factor Ctip2 controls epidermal lipid metabolism and regulates expression of genes involved in sphingolipid biosynthesis during skin development.","date":"2012","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/23096701","citation_count":24,"is_preprint":false},{"pmid":"33936112","id":"PMC_33936112","title":"Epigenetic Dynamics in the Function of T-Lineage Regulatory Factor Bcl11b.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/33936112","citation_count":24,"is_preprint":false},{"pmid":"33376550","id":"PMC_33376550","title":"miR-21-5p promotes cell proliferation by targeting BCL11B in Thp-1 cells.","date":"2020","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/33376550","citation_count":23,"is_preprint":false},{"pmid":"29749698","id":"PMC_29749698","title":"Downregulated miR-17, miR-29c, miR-92a and miR-214 may be related to BCL11B overexpression in T cell acute lymphoblastic leukemia.","date":"2018","source":"Asia-Pacific journal of clinical oncology","url":"https://pubmed.ncbi.nlm.nih.gov/29749698","citation_count":23,"is_preprint":false},{"pmid":"31447328","id":"PMC_31447328","title":"CTIP2-Regulated Reduction in PKA-Dependent DARPP32 Phosphorylation in Human Medium Spiny Neurons: Implications for Huntington Disease.","date":"2019","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/31447328","citation_count":23,"is_preprint":false},{"pmid":"25827435","id":"PMC_25827435","title":"Bcl11b SWI/SNF-complex subunit modulates intestinal adenoma and regeneration after γ-irradiation through Wnt/β-catenin pathway.","date":"2015","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/25827435","citation_count":21,"is_preprint":false},{"pmid":"23383087","id":"PMC_23383087","title":"Reduced level of the BCL11B protein is associated with adult T-cell leukemia/lymphoma.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23383087","citation_count":20,"is_preprint":false},{"pmid":"30497506","id":"PMC_30497506","title":"Genomics of neonatal sepsis: has-miR-150 targeting BCL11B functions in disease progression.","date":"2018","source":"Italian journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/30497506","citation_count":20,"is_preprint":false},{"pmid":"33363142","id":"PMC_33363142","title":"Bcl11b/Ctip2 in Skin, Tooth, and Craniofacial System.","date":"2020","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/33363142","citation_count":19,"is_preprint":false},{"pmid":"31479431","id":"PMC_31479431","title":"Chimeric antigen receptor-induced BCL11B suppression propagates NK-like cell development.","date":"2019","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/31479431","citation_count":19,"is_preprint":false},{"pmid":"27790219","id":"PMC_27790219","title":"Transcription Factor Bcl11b Controls Effector and Memory CD8 T cell Fate Decision and Function during Poxvirus Infection.","date":"2016","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/27790219","citation_count":19,"is_preprint":false},{"pmid":"33725769","id":"PMC_33725769","title":"Human Adipose-derived mesenchymal stem cells promote lymphocyte apoptosis and alleviate atherosclerosis via miR-125b-1-3p/BCL11B signal axis.","date":"2021","source":"Annals of palliative medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33725769","citation_count":19,"is_preprint":false},{"pmid":"38632339","id":"PMC_38632339","title":"PU.1 and BCL11B sequentially cooperate with RUNX1 to anchor mSWI/SNF to poise the T cell effector landscape.","date":"2024","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/38632339","citation_count":18,"is_preprint":false},{"pmid":"32164354","id":"PMC_32164354","title":"High Specificity of BCL11B and GLG1 for EWSR1-FLI1 and EWSR1-ERG Positive Ewing Sarcoma.","date":"2020","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/32164354","citation_count":18,"is_preprint":false},{"pmid":"30088373","id":"PMC_30088373","title":"Bcl11b Regulates IL-17 Through the TGF-β/Smad Pathway in HDM-Induced Asthma.","date":"2018","source":"Allergy, asthma & immunology research","url":"https://pubmed.ncbi.nlm.nih.gov/30088373","citation_count":18,"is_preprint":false},{"pmid":"27577752","id":"PMC_27577752","title":"N-acetylcysteine attenuates lipopolysaccharide-induced impairment in lamination of Ctip2-and Tbr1- expressing cortical neurons in the developing rat fetal brain.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27577752","citation_count":18,"is_preprint":false},{"pmid":"34865701","id":"PMC_34865701","title":"Redefining the biological basis of lineage-ambiguous leukemia through genomics: BCL11B deregulation in acute leukemias of ambiguous lineage.","date":"2021","source":"Best practice & research. Clinical haematology","url":"https://pubmed.ncbi.nlm.nih.gov/34865701","citation_count":18,"is_preprint":false},{"pmid":"27586877","id":"PMC_27586877","title":"Identification of BCL11B as a regulator of adipogenesis.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27586877","citation_count":17,"is_preprint":false},{"pmid":"33093445","id":"PMC_33093445","title":"BCL11B suppresses tumor progression and stem cell traits in hepatocellular carcinoma by restoring p53 signaling activity.","date":"2020","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/33093445","citation_count":17,"is_preprint":false},{"pmid":"22426257","id":"PMC_22426257","title":"The role of BCL11B in regulating the proliferation of human naive T cells.","date":"2012","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/22426257","citation_count":17,"is_preprint":false},{"pmid":"19432895","id":"PMC_19432895","title":"Haploinsufficiency and acquired loss of Bcl11b and H2AX induces blast crisis of chronic myelogenous leukemia in a transgenic mouse model.","date":"2009","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/19432895","citation_count":17,"is_preprint":false},{"pmid":"25422283","id":"PMC_25422283","title":"Bcl11b prevents the intrathymic development of innate CD8 T cells in a cell intrinsic manner.","date":"2014","source":"International immunology","url":"https://pubmed.ncbi.nlm.nih.gov/25422283","citation_count":17,"is_preprint":false},{"pmid":"20513151","id":"PMC_20513151","title":"Proteome analysis reveals new mechanisms of Bcl11b-loss driven apoptosis.","date":"2010","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/20513151","citation_count":17,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":45964,"output_tokens":8694,"usd":0.134151},"stage2":{"model":"claude-opus-4-6","input_tokens":12548,"output_tokens":4670,"usd":0.269235},"total_usd":0.403386,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2007,\n      \"finding\": \"CTIP2/BCL11B recruits histone deacetylases HDAC1 and HDAC2 to the HIV-1 promoter to promote local histone H3 deacetylation, and associates with histone methyltransferase SUV39H1 to increase H3K9 methylation, enabling HP1 protein recruitment and heterochromatin formation that silences HIV-1 transcription in microglial cells.\",\n      \"method\": \"ChIP, co-IP, transfection/reporter assays, pharmacological inhibition\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal biochemical methods (ChIP, co-IP, enzymatic assays) in a single rigorous study\",\n      \"pmids\": [\"17245431\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"CTIP2/BCL11B interacts with HP1α and HIV-1 Tat protein to form a three-protein complex, relocalizing Tat into CTIP2-induced nuclear heterochromatic structures via two distinct CTIP2 domains (aa 145-434 interacting with Tat N-terminus; aa 717-813 interacting with HP1), thereby inhibiting Tat-mediated HIV-1 transactivation.\",\n      \"method\": \"Co-IP, confocal microscopy, deletion mutagenesis, reporter assays\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — domain mapping with deletion mutants plus co-IP and imaging, multiple orthogonal methods\",\n      \"pmids\": [\"12692243\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"CTIP2/BCL11B associates with the NuRD chromatin-remodeling/deacetylase complex through direct interaction with RbAp46 and RbAp48; NuRD components are recruited to a promoter template in a CTIP2-dependent manner, and both CTIP2 and NuRD co-occupy the p57KIP2 promoter to repress its transcription.\",\n      \"method\": \"Co-IP, pulldown, ChIP, reporter assays in SK-N-MC neuroblastoma cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct interaction demonstrated by pulldown, ChIP co-occupancy, and reporter assays\",\n      \"pmids\": [\"16950772\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CTIP2/BCL11B and SUV39H1 are co-recruited to the p21WAF1 gene promoter, where CTIP2 cooperates with SUV39H1 to promote H3K9 trimethylation and silence p21 transcription; chaetocin (SUV39H1 inhibitor) treatment relieves this repression.\",\n      \"method\": \"ChIP, siRNA knockdown, pharmacological inhibition, reporter assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — ChIP plus functional rescue with pharmacological inhibitor and knockdown\",\n      \"pmids\": [\"19581932\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"CTIP2/BCL11B is a negative regulator of P-TEFb: it copurifies and directly interacts with HEXIM1 and, via the 7SK snRNA loop 2, with P-TEFb to form an inactive complex, significantly repressing CDK9 kinase activity and thereby suppressing P-TEFb-sensitive gene expression including at the MYH7 promoter in cardiomyopathic hearts.\",\n      \"method\": \"Co-purification, co-IP, in vitro CDK9 kinase assay, ChIP, siRNA knockdown, genome-wide transcriptomics\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay plus multiple co-IP and ChIP experiments, genome-wide validation\",\n      \"pmids\": [\"23852730\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"BCL11B is required for T lineage commitment in mice; it specifically represses natural killer cell-associated genes and downregulates stem/progenitor cell genes at the DN2-to-DN3 transition stage.\",\n      \"method\": \"Bcl11b knockout mouse model, gene expression profiling, flow cytometry\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular phenotype and gene expression readout, replicated across labs\",\n      \"pmids\": [\"20595614\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Deletion of Bcl11b in T cells causes them to acquire NK cell properties (morphologically and genetically similar to conventional NK cells) with retained tumor-killing capacity, demonstrating Bcl11b is required to maintain T cell identity and suppress NK cell programming.\",\n      \"method\": \"Conditional Bcl11b knockout, gene expression profiling, functional cytotoxicity assays, in vivo tumor metastasis model\",\n      \"journal\": \"Science (New York, N.Y.)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with multiple orthogonal functional readouts, replicated concept across labs\",\n      \"pmids\": [\"20538915\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Bcl11b is required for Tcrb V(D)J recombination (specifically Vβ-to-Dβ joining), pre-TCR complex surface expression, and thymocyte survival; Bcl11b-deficient mice are blocked at the CD4−CD8− double-negative stage with profound thymic apoptosis.\",\n      \"method\": \"Bcl11b knockout mouse model, flow cytometry, PCR-based recombination assay, Northern blot\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with specific molecular and cellular phenotype; foundational paper with >300 citations\",\n      \"pmids\": [\"12717433\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"BCL11B controls positive selection of both CD4 and CD8 thymocytes by maintaining proximal TCR signaling components; BCL11B-deficient DP thymocytes show impaired ERK phosphorylation and calcium flux, and increased spontaneous apoptosis associated with elevated caspase-3 cleavage and altered pro-/anti-apoptotic factor balance, only partially rescued by BCL2 transgene.\",\n      \"method\": \"Conditional knockout, flow cytometry, calcium flux assay, ERK phosphorylation assay, transgenic TCR rescue experiments, apoptosis assays\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal functional assays including rescue experiments\",\n      \"pmids\": [\"17998389\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Ctip2/BCL11B acts downstream of Fezf2 to regulate subcortical axon projection fate in the cerebral cortex; ectopic Ctip2 expression redirects callosal neurons to project subcortically and rescues the axonal phenotype of Fezf2 knockout mice.\",\n      \"method\": \"Knockout mice, in utero electroporation, axon tracing, epistasis analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with rescue experiment, multiple orthogonal readouts\",\n      \"pmids\": [\"18678899\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Ctip2/BCL11B is required for medium spiny neuron (MSN) differentiation and striatal architecture; Ctip2-null mice show dramatically reduced expression of MSN markers (DARPP-32, FOXP1, Chrm4, Reelin, MOR1, GluR1, Plexin-D1), failure of MSN patch aggregation, and abnormal dopaminergic innervation.\",\n      \"method\": \"Ctip2 knockout mouse model, immunohistochemistry, in situ hybridization, gene expression analysis\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with multiple specific molecular and anatomical readouts\",\n      \"pmids\": [\"18199763\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Bcl11b expression is activated by an asynchronous combination of four regulatory inputs: TCF-1 and GATA-3 provide early locus 'poising', Notch signaling provides stochastic permissivity, and Runx1 controls amplitude; these act via a far downstream enhancer (Major Peak, ~850 kb from the Bcl11b promoter) that loops to interact with the promoter.\",\n      \"method\": \"Bcl11b knock-in fluorescent reporter mice, single-cell live imaging, genetic deletion of transcription factors, looping/enhancer assays\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — single-cell reporter system with systematic genetic dissection of four factors\",\n      \"pmids\": [\"27376470\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"A 1.9-kb enhancer element ('Major Peak') located ~850 kb downstream of Bcl11b is required for T-cell-specific Bcl11b expression; it contains TCF-1 binding sites and a conserved element needed for T-lineage activation and silencing in non-T cells, and physically loops to interact with the Bcl11b promoter-proximal region.\",\n      \"method\": \"Stable reporter assays, bacterial artificial chromosome transgenics, chromatin looping assays, deletion mutagenesis\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — enhancer function confirmed by stable reporter and BAC transgenics with mutagenesis\",\n      \"pmids\": [\"23741008\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"LSD1 histone demethylase cooperates with CTIP2 to repress HIV-1 transcription; LSD1 is recruited to the HIV-1 proximal promoter where its activity is associated with H3K4me3 and H3K9me3 epigenetic marks, and LSD1-induced H3K4 trimethylation is linked to hSET1 recruitment.\",\n      \"method\": \"ChIP, siRNA knockdown, reporter assays, co-IP\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP and co-IP from single lab\",\n      \"pmids\": [\"22067449\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"HMGA1 recruits the CTIP2-repressed inactive P-TEFb/7SK snRNP complex to cellular gene promoters and the HIV-1 promoter; knockdown of HMGA1 reduces ChIP signal for CTIP2/7SK/P-TEFb at these promoters, and CTIP2 and HMGA1 act synergistically to repress P-TEFb-dependent gene expression.\",\n      \"method\": \"ChIP, siRNA dual knockdown, reporter assays, co-IP\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP and functional knockdown, single lab\",\n      \"pmids\": [\"24623795\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Bcl11b/Ctip2 regulates hippocampal dentate gyrus postnatal neurogenesis through a dual mechanism: feedback control of the progenitor cell compartment and regulation of granule cell differentiation; Desmoplakin is identified as a direct transcriptional target of Bcl11b, and re-expression of Desmoplakin in Bcl11b mutants rescues impaired neurogenesis.\",\n      \"method\": \"Forebrain-specific conditional knockout, ChIP (direct target validation), rescue experiments, behavioral testing\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — ChIP-confirmed direct target with rescue experiment and functional behavioral readout\",\n      \"pmids\": [\"22588081\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Bcl11b directly binds to Foxp3 and IL-10 gene promoters and conserved noncoding sequences; mutation of the Bcl11b binding site in the Foxp3 promoter reduces reporter expression, demonstrating Bcl11b directly activates Foxp3 and IL-10 transcription in T regulatory cells.\",\n      \"method\": \"ChIP, promoter mutation/reporter assay, conditional knockout\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct binding confirmed by ChIP with functional promoter mutagenesis\",\n      \"pmids\": [\"21875956\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"BCL11B structural mutations in T-ALL disrupt zinc finger domain structure required for DNA binding, as revealed by structural homology modeling; missense mutations in zinc finger domains abrogate the protein's DNA-binding capacity.\",\n      \"method\": \"Structural homology modeling, DNA copy number analysis, sequencing of patient specimens\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3-4 — structural modeling without direct biochemical validation of mutant DNA binding\",\n      \"pmids\": [\"21878675\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"BCL11B homodimerizes through its N-terminal CCHC zinc finger motif; this dimerization is necessary and sufficient for transcriptional regulatory activity, cell cycle arrest induction, and protection against DNA damage-driven apoptosis. The pathogenic N441K dominant-negative mutation acts by forming a nonfunctional dimer with wild-type BCL11B.\",\n      \"method\": \"FACS-FRET assay, affinity purification/mass spectrometry, CCHC zinc finger mutagenesis, cell cycle analysis, apoptosis assay\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — domain mapping with mutagenesis plus multiple functional readouts in single rigorous study\",\n      \"pmids\": [\"29203643\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"A patient de novo missense mutation p.N441K in BCL11B produces a dominant-negative protein that abrogates wild-type BCL11B's ability to bind DNA, arresting T-cell development and disrupting hematopoietic stem cell migration; this reveals a prethymic role for BCL11B in hematopoietic progenitor migration.\",\n      \"method\": \"Exome sequencing, functional assays in human HSCs, zebrafish bcl11ba knockout rescue with wild-type vs. mutant human BCL11B\",\n      \"journal\": \"The New England journal of medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vivo rescue experiment in zebrafish plus human HSC functional assay\",\n      \"pmids\": [\"27959755\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Bcl11b controls antigen-dependent CD8+ T cell clonal expansion and cytolytic activity; it directly binds the E8I, E8IV, and E8V enhancers (but not E8II/E8III) to maintain optimal CD8 coreceptor expression, and Bcl11b-deficient CD8 T cells show deregulated Plcgamma1 and reduced granzyme B and perforin.\",\n      \"method\": \"ChIP (enhancer binding), conditional knockout, viral infection model, flow cytometry, cytotoxicity assay\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — ChIP-confirmed enhancer binding with in vivo functional readouts\",\n      \"pmids\": [\"20660613\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Bcl11b in DP thymocytes controls iNKT cell positive selection by regulating glycolipid self-antigen presentation via control of lysosomal gene expression; Bcl11b-deficient DP thymocytes show enlarged lysosomes, accumulation of glycosphingolipids, and altered expression of lysosomal proteins including cathepsins and Niemann-Pick genes.\",\n      \"method\": \"Conditional knockout, electron microscopy, flow cytometry, gene expression analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with specific biochemical and cellular phenotype, multiple readouts\",\n      \"pmids\": [\"21444811\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"BCL11B functions as a transcriptional repressor in Ewing sarcoma through the NuRD co-repressor complex; it contributes to the EWS/FLI repressed gene signature and represses SPRY1, whose re-expression limits Ewing sarcoma transformation capacity.\",\n      \"method\": \"ChIP, siRNA knockdown, re-expression experiments, colony formation assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — ChIP and functional rescue, single lab\",\n      \"pmids\": [\"23527175\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Bcl11b-knockdown T-cell lines show apoptosis in S phase with decreased p27 and Bcl-xL due to transcriptional repression, linked to impairment of Sirt1 (a NAD+-dependent deacetylase that associates with Bcl11b); this leads to Claspin cleavage and failure to phosphorylate Chk1, implicating Bcl11b in DNA replication stress response and genomic integrity maintenance.\",\n      \"method\": \"siRNA knockdown, Sirt1 co-immunoprecipitation, cell cycle analysis, Chk1 phosphorylation assay, UV irradiation of Bcl11b-/- thymocytes\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — co-IP with functional kinase readout, single lab\",\n      \"pmids\": [\"17369851\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Bcl11b directly represses Id2 in early T-lineage cells to prevent innate lymphoid/NK fate adoption, but in ILC2s Bcl11b and Id2 are co-expressed; Bcl11b binding shows cell-type-specific genomic occupancy patterns and controls entirely different target gene sets in pro-T cells vs. ILC2s, and carries cell-type-specific post-translational modifications and protein complex compositions.\",\n      \"method\": \"ChIP-seq, conditional knockout in both lineages, mass spectrometry of protein complexes, reporter assays\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genome-wide ChIP-seq plus MS-characterized complexes in two cell types with KO validation\",\n      \"pmids\": [\"31653691\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Bcl11b acts directly upstream of Gfi1 to maintain its expression in mature ILC2s; in the absence of Bcl11b, Gata3 and IL-33 receptor (Il1rl1) are downregulated, and Bcl11b independently represses the ILC3 transcription factor Ahr to maintain ILC2 lineage fidelity.\",\n      \"method\": \"Conditional Bcl11b knockout in ILC2s, gene expression profiling, ChIP (direct regulation of Gfi1 and Ahr), cytokine assays\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-confirmed direct targets with conditional KO and functional cytokine readouts\",\n      \"pmids\": [\"26231117\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Bcl11b primes the ThPOK and Runx3 lineage-specifying genes prior to TCR selection, with initial Thpok repression dependent on the last zinc finger motif of Bcl11b (distinct from the zinc finger required for T-lineage commitment), thereby coupling TCR MHC-restriction signals to the transcriptional program for CD4/CD8 lineage choice.\",\n      \"method\": \"Bcl11b conditional knockout, zinc finger point mutant (Bcl11b F/S826G), reporter assays, TCR-transgenic rescue\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — domain-specific zinc finger mutant with epistasis and TCR-transgenic rescue\",\n      \"pmids\": [\"28951542\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Bcl11b binds GATA3 through protein-protein interaction and co-localizes with GATA3 at cis-regulatory elements in Th2 cells; Bcl11b-deficient Th2 cells show GATA3-dependent upregulation of IL-4, IL-5, and IL-13, indicating Bcl11b limits GATA3-mediated type 2 cytokine gene expression.\",\n      \"method\": \"Co-IP (protein-protein interaction), ChIP-seq, RNA-seq, conditional knockout\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct interaction confirmed by co-IP with genome-wide co-occupancy and KO functional readout\",\n      \"pmids\": [\"29514917\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Bcl11b maintains chromatin accessibility at Th2-cytokine promoters and locus-control regions, binds the Il4 HS IV silencer to reduce its accessibility, binds GATA3 intronic/downstream noncoding sites to sustain Gata3 expression, and binds/deactivates upstream Runx3 enhancers to restrict Runx3 expression and its repressive activity at Il4 HS IV.\",\n      \"method\": \"ATAC-seq, ChIP, conditional knockout, helminth infection model\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — ATAC-seq plus ChIP with in vivo functional model\",\n      \"pmids\": [\"29700302\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Genome-wide ChIP-seq in striatal cells identifies Bcl11b binding sites predominantly within 10 kb of transcription start sites; integration with expression profiling identifies 248 direct Bcl11b targets including components of the BDNF/neurotrophin signaling pathway, and reveals consensus DNA-binding motifs for Bcl11b.\",\n      \"method\": \"ChIP-seq, microarray expression profiling, Bcl11b overexpression\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — genome-wide ChIP-seq with expression integration, single lab\",\n      \"pmids\": [\"21912641\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Ctip2/BCL11B is required for ameloblast formation in tooth development; it controls expression of amelogenin, ameloblastin, enamelin, Msx2, and epiprofin, and regulates ameloblast morphology, polarization, and adhesion properties.\",\n      \"method\": \"Conditional and germline Ctip2 knockout, immunohistochemistry, in situ hybridization, gene expression analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with specific molecular and cellular readouts in defined developmental context\",\n      \"pmids\": [\"19251658\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Ctip2 controls keratinocyte proliferation and differentiation by directly and positively regulating EGFR transcription in proliferating cells and Notch1 transcription in differentiating cells; EGFR signaling downregulates Ctip2 mRNA, while high calcium signaling triggers Ctip2 SUMOylation, ubiquitination and proteasomal degradation, forming a negative feedback loop.\",\n      \"method\": \"ChIP (EGFR and Notch1 promoter occupancy), knockdown/overexpression, Western blot, promoter reporter assay\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — ChIP-confirmed direct transcriptional targets plus biochemical characterization of PTM-driven degradation\",\n      \"pmids\": [\"23015591\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Ctip2 is recruited to promoters of sphingolipid biosynthesis genes in developing skin and regulates epidermal ceramide and sphingomyelin composition; loss of Ctip2 alters major epidermal lipid species as measured by targeted lipidomics.\",\n      \"method\": \"ChIP, targeted lipidomics by mass spectrometry, Ctip2 knockout mouse\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — ChIP confirmed recruitment, single lab with lipidomics readout\",\n      \"pmids\": [\"23096701\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Keratinocytic Ctip2 directly represses TSLP transcription as demonstrated by ChIP; Ctip2 deletion leads to TSLP upregulation, triggering atopic dermatitis-like skin inflammation with Th2-type cytokine responses and immune cell infiltration.\",\n      \"method\": \"Conditional epidermal Ctip2 knockout, ChIP (TSLP promoter), histology, cytokine profiling\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — ChIP-confirmed direct repression with in vivo inflammatory phenotype, single lab\",\n      \"pmids\": [\"23284675\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Bcl11b acts as a SWI/SNF complex subunit and regulates intestinal adenoma development; Bcl11b attenuation in Lgr5+ crypt base columnar cells increases expression of β-catenin target genes (c-Myc, cyclin D1), and BCL11B introduction in human cell lines downregulates β-catenin target gene transcription.\",\n      \"method\": \"Bcl11b heterozygous mice crossed to ApcMin/+, reporter assays, gene expression analysis in intestinal stem cells\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — genetic model with reporter assay, single lab\",\n      \"pmids\": [\"25827435\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HIV-1 Vpr promotes proteasomal degradation of CTIP2 in microglial cells and CD4+ T cells via association with the Cul4A-DDB1-DCAF1 ubiquitin ligase complex, targeting CTIP2 at the latent HIV-1 promoter where it is associated with heterochromatin-promoting enzymes, thereby reactivating HIV-1 expression.\",\n      \"method\": \"Co-IP, proteasome inhibitor treatment, ChIP, siRNA/dominant-negative experiments in microglial HIV-1 latency model\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — co-IP plus proteasome inhibitor rescue with ChIP, single lab\",\n      \"pmids\": [\"31511615\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Bcl11b determines odorant receptor class choice in olfactory sensory neurons: loss-of-function biases OR choice toward class I (default), while gain-of-function biases toward class II; Bcl11b promotes class II OR expression by suppressing the activity of the J-element, a class I-OR enhancer.\",\n      \"method\": \"OSN-specific conditional Bcl11b knockout and overexpression, single-cell analysis, enhancer reporter assays, innate olfactory behavior assays\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — bidirectional gain/loss-of-function with enhancer mechanism and behavioral readout\",\n      \"pmids\": [\"31396576\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CTIP2-deficient human medium spiny neurons derived from hPSCs show substantial reduction in phosphorylation of DARPP32 and GluR1 (two PKA targets), implicating CTIP2 in regulating PKA signaling in striatal neurons; transcriptomic analysis confirms CTIP2 targets are at the core of cAMP-Ca2+ signal integration in the PKA pathway.\",\n      \"method\": \"CTIP2-deficient human PSC-derived MSNs, phosphoprotein analysis, transcriptomics, HD mouse model comparison\",\n      \"journal\": \"Stem cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — KO-based phosphoproteomic readout, single lab, human and mouse models\",\n      \"pmids\": [\"31447328\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"BCL11B succeeds PU.1 in a transcription factor 'relay' to maintain mSWI/SNF chromatin remodeling complex occupancy together with RUNX1 at T effector loci after PU.1 silencing during T lineage commitment, thereby poising the T cell effector chromatin landscape early in development.\",\n      \"method\": \"ChIP-seq, ATAC-seq, conditional knockout of PU.1 and BCL11B, mSWI/SNF co-immunoprecipitation\",\n      \"journal\": \"Nature immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genome-wide ChIP-seq with co-IP and conditional KO, mechanistic relay model with multiple orthogonal methods\",\n      \"pmids\": [\"38632339\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"BCL11B/CTIP2 is a zinc finger transcription factor that functions as both a transcriptional repressor and activator depending on cell context: it recruits chromatin-modifying enzyme complexes (NuRD, HDAC1/2, SUV39H1, LSD1) to silence target genes including HIV-1 and p21WAF1; sequesters and inhibits P-TEFb kinase activity via interaction with the 7SK/HEXIM1 complex; homodimerizes through its N-terminal CCHC zinc finger domain (required for transcriptional activity); directly binds DNA at specific motifs and also interacts with partner transcription factors (GATA3, COUP-TF, RUNX1) to regulate distinct gene programs; recruits mSWI/SNF chromatin remodeling complexes to poise effector T cell loci; and acts as a master transcriptional regulator of T lineage commitment, ILC2 identity, cortical/striatal neuron differentiation, and epidermal homeostasis by controlling lineage-specific gene networks through context-dependent post-translational modifications and protein complex compositions.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"BCL11B (CTIP2) is a C2H2/CCHC zinc finger transcription factor that serves as a master regulator of cell identity across multiple lineages, including T lymphocytes, innate lymphoid cells, cortical and striatal neurons, olfactory sensory neurons, keratinocytes, and ameloblasts. It functions as both a transcriptional repressor and activator in a context-dependent manner: as a repressor, it recruits the NuRD chromatin-remodeling complex, HDAC1/2, SUV39H1, and LSD1 to silence targets such as HIV-1, p21WAF1, TSLP, and Id2 through heterochromatin establishment [PMID:17245431, PMID:16950772, PMID:19581932]; as an activator, it directly binds and sustains expression of lineage-critical genes including Foxp3, Gfi1, EGFR, and Notch1, and cooperates with RUNX1 to recruit mSWI/SNF complexes to poise T cell effector loci [PMID:21875956, PMID:26231117, PMID:38632339]. BCL11B homodimerizes through its N-terminal CCHC zinc finger—a requirement for transcriptional activity—and its genomic occupancy, post-translational modifications, and protein complex composition differ between cell types, enabling it to control distinct gene programs in pro-T cells versus ILC2s [PMID:29203643, PMID:31653691]. De novo BCL11B mutations cause human immunodeficiency with arrested T-cell development and impaired hematopoietic progenitor migration [PMID:27959755].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"Early work established that BCL11B is essential for T-cell development and identified its role as a heterochromatin organizer: Bcl11b knockout mice revealed a block at the DN stage with failed V(D)J recombination, while domain mapping showed BCL11B sequesters HIV-1 Tat into HP1α-containing heterochromatic structures to silence viral transcription.\",\n      \"evidence\": \"Bcl11b germline knockout with recombination PCR and flow cytometry; co-IP/confocal with deletion mutants in transfected cells\",\n      \"pmids\": [\"12717433\", \"12692243\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which BCL11B controls V(D)J recombination accessibility was not defined\", \"Whether HP1α interaction is required for endogenous gene silencing beyond HIV-1 was untested\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"The chromatin-modifying machinery through which BCL11B silences genes was delineated: BCL11B recruits HDAC1/2 and SUV39H1 to the HIV-1 promoter to establish H3 deacetylation and H3K9 trimethylation, and a parallel study linked BCL11B to Sirt1 and the DNA replication stress response through Chk1 phosphorylation.\",\n      \"evidence\": \"ChIP, co-IP, and pharmacological inhibition in microglial cells; siRNA knockdown with Sirt1 co-IP and Chk1 phosphorylation assay in T-cell lines\",\n      \"pmids\": [\"17245431\", \"17369851\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HDAC1/2 and SUV39H1 are recruited as a single complex or sequentially was unresolved\", \"Sirt1–BCL11B interaction lacked independent replication\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"BCL11B was shown to physically associate with the NuRD complex through direct binding to RbAp46/48, establishing NuRD as a major effector of BCL11B-mediated transcriptional repression at endogenous gene promoters such as p57KIP2.\",\n      \"evidence\": \"Co-IP, in vitro pulldown, and ChIP co-occupancy at the p57KIP2 promoter in neuroblastoma cells\",\n      \"pmids\": [\"16950772\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full stoichiometry and subunit composition of the BCL11B–NuRD complex were not determined\", \"Whether NuRD mediates all BCL11B repressive functions or only a subset was unclear\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"BCL11B's roles in neuronal fate specification were established: it acts downstream of Fezf2 to direct subcortical axon projections of corticospinal neurons, and is required for medium spiny neuron differentiation and striatal patch organization.\",\n      \"evidence\": \"Epistasis analysis with in utero electroporation and axon tracing in Fezf2-KO rescue; Ctip2 knockout with immunohistochemistry and in situ hybridization for MSN markers\",\n      \"pmids\": [\"18678899\", \"18199763\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcriptional targets mediating axon guidance decisions were not identified\", \"Whether BCL11B acts through NuRD or distinct complexes in neurons was unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"BCL11B was identified as the gatekeeper of T-cell versus NK-cell identity: its deletion in committed T cells reprograms them into functional NK-like cells, and it acts at the DN2-to-DN3 transition to repress NK-associated and stem cell genes, while also directly binding CD8 enhancers to control effector T-cell function.\",\n      \"evidence\": \"Conditional and germline Bcl11b knockouts with gene expression profiling, cytotoxicity assays, in vivo tumor and viral infection models, ChIP at CD8 enhancers\",\n      \"pmids\": [\"20595614\", \"20538915\", \"20660613\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether T-to-NK reprogramming occurs through a multipotent intermediate was unresolved\", \"The complete set of BCL11B-repressed NK genes was not defined genome-wide\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"BCL11B's direct transcriptional targets were expanded to include Foxp3 and IL-10 in Tregs, lysosomal genes controlling iNKT cell selection, and neurotrophin pathway components in the striatum, while LSD1 was identified as an additional BCL11B-cooperating chromatin modifier at the HIV-1 promoter.\",\n      \"evidence\": \"ChIP with promoter mutagenesis in Tregs; conditional KO with electron microscopy and lipid analysis for iNKT; ChIP-seq with expression profiling in striatal cells; ChIP/co-IP for LSD1 at HIV-1 promoter\",\n      \"pmids\": [\"21875956\", \"21444811\", \"21912641\", \"22067449\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How BCL11B switches from repressor to activator at Foxp3 was mechanistically unexplained\", \"LSD1 cooperation was characterized at HIV-1 but not validated at endogenous targets\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"BCL11B's functions were extended to epithelial biology and hippocampal neurogenesis: it directly activates EGFR and Notch1 in keratinocytes, regulates sphingolipid biosynthesis genes in skin, represses TSLP to prevent atopic dermatitis, and controls dentate gyrus neurogenesis through Desmoplakin as a direct target.\",\n      \"evidence\": \"ChIP at EGFR/Notch1/TSLP/sphingolipid promoters; conditional epidermal and forebrain KO models; rescue of neurogenesis by Desmoplakin re-expression; lipidomics\",\n      \"pmids\": [\"23015591\", \"23096701\", \"23284675\", \"22588081\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How calcium-induced SUMOylation and proteasomal degradation of BCL11B are coordinated in vivo was not fully resolved\", \"Whether sphingolipid changes are a primary or secondary consequence of BCL11B loss was unclear\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"A kinase-independent function was revealed: BCL11B directly interacts with HEXIM1 and the 7SK snRNP to sequester P-TEFb, repressing CDK9 kinase activity at target promoters including MYH7 in cardiomyopathic hearts, while a distal enhancer (~850 kb downstream) was identified as the T-cell-specific regulatory element that activates BCL11B expression through chromatin looping.\",\n      \"evidence\": \"In vitro CDK9 kinase assay, co-purification and ChIP in cardiac cells; BAC transgenics and chromatin looping assays for enhancer\",\n      \"pmids\": [\"23852730\", \"23741008\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether P-TEFb sequestration is a general mechanism at all BCL11B-repressed promoters was untested\", \"Factors controlling enhancer–promoter loop formation beyond TCF-1 were not fully defined\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"The upstream regulatory logic activating BCL11B expression during T-cell commitment was decoded: four inputs (TCF-1, GATA-3, Notch, Runx1) converge on the distal enhancer with distinct kinetics—poising, stochastic permissivity, and amplitude control—resolving how BCL11B activation timing is regulated.\",\n      \"evidence\": \"Bcl11b knock-in fluorescent reporter with single-cell live imaging; systematic genetic deletion of each factor\",\n      \"pmids\": [\"27376470\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Epigenetic state transitions at the enhancer during each regulatory input were not fully mapped\", \"Whether the same regulatory logic operates in non-T lineages expressing BCL11B was unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"A de novo BCL11B missense mutation (N441K) was shown to cause human immunodeficiency by acting as a dominant-negative that abrogates DNA binding and arrests T-cell development, also revealing a previously unappreciated prethymic role for BCL11B in hematopoietic progenitor migration.\",\n      \"evidence\": \"Exome sequencing of patient; zebrafish bcl11ba KO rescue with WT versus mutant human BCL11B; human HSC migration assays\",\n      \"pmids\": [\"27959755\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The molecular mechanism of prethymic migration control was not defined\", \"Whether other BCL11B mutations cause the same syndrome was not yet established\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"BCL11B's oligomeric state was resolved: it homodimerizes through the N-terminal CCHC zinc finger, and this dimerization is necessary for transcriptional activity, cell cycle arrest, and protection from DNA damage; the N441K pathogenic mutation acts by forming nonfunctional dimers with wild-type protein.\",\n      \"evidence\": \"FACS-FRET, AP-MS, CCHC zinc finger mutagenesis, cell cycle and apoptosis assays\",\n      \"pmids\": [\"29203643\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether BCL11B can also heterodimerize with BCL11A was not addressed\", \"Structural basis of the dimer interface at atomic resolution was lacking\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"BCL11B's interaction with GATA3 was characterized as a direct protein–protein association at co-occupied Th2 cis-regulatory elements, where BCL11B restrains GATA3-driven type 2 cytokine overproduction and maintains chromatin accessibility at cytokine loci while silencing the Il4 HS IV element through Runx3 restriction.\",\n      \"evidence\": \"Co-IP, ChIP-seq, ATAC-seq, RNA-seq, conditional KO in Th2 cells, helminth infection model\",\n      \"pmids\": [\"29514917\", \"29700302\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of BCL11B–GATA3 interaction was undetermined\", \"Whether this restraining mechanism operates in human Th2-driven disease was untested in vivo\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Context-dependent BCL11B function was mechanistically explained: ChIP-seq in pro-T cells versus ILC2s showed largely non-overlapping genomic binding, with distinct post-translational modifications and partner complexes in each lineage; simultaneously, BCL11B was shown to determine odorant receptor class choice in olfactory neurons and regulate PKA signaling in human striatal neurons.\",\n      \"evidence\": \"ChIP-seq and MS of BCL11B complexes in two lineages with conditional KO; OSN-specific KO/overexpression with enhancer reporters; CTIP2-deficient hPSC-derived MSNs with phosphoprotein analysis\",\n      \"pmids\": [\"31653691\", \"31396576\", \"31447328\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific PTMs driving cell-type-specific binding were not fully catalogued\", \"Whether BCL11B directly regulates PKA pathway genes or acts indirectly through DARPP-32 was unclear\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"HIV-1 Vpr was found to counteract BCL11B-mediated latency by targeting CTIP2 for proteasomal degradation via the Cul4A–DDB1–DCAF1 ubiquitin ligase complex, revealing a viral strategy to reactivate latent provirus by eliminating its silencing factor.\",\n      \"evidence\": \"Co-IP, proteasome inhibitor rescue, ChIP at latent HIV-1 promoter, siRNA/dominant-negative in microglial latency model\",\n      \"pmids\": [\"31511615\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether Vpr-mediated BCL11B degradation occurs in primary latently infected CD4+ T cells in vivo was not demonstrated\", \"Quantitative contribution of BCL11B degradation versus other Vpr targets to latency reversal was unresolved\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"BCL11B was shown to participate in a transcription factor relay with PU.1 during T lineage commitment: as PU.1 is silenced, BCL11B together with RUNX1 takes over mSWI/SNF complex recruitment at T effector loci, maintaining chromatin accessibility and poising the effector gene program early in development.\",\n      \"evidence\": \"ChIP-seq and ATAC-seq with conditional KO of PU.1 and BCL11B; mSWI/SNF co-immunoprecipitation\",\n      \"pmids\": [\"38632339\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether BCL11B is a stable mSWI/SNF subunit or a transient recruiter was not resolved\", \"How BCL11B discriminates between mSWI/SNF-dependent and NuRD-dependent targets at the same developmental stage is unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the structural basis of BCL11B homodimerization and partner interactions; how post-translational modifications switch BCL11B between activator and repressor modes; and the full spectrum of human disease caused by BCL11B mutations beyond the initial immunodeficiency case.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of BCL11B or its complexes exists\", \"Systematic mapping of PTMs to functional outputs across cell types is lacking\", \"Genotype–phenotype relationships for BCL11B variants in neurodevelopmental and immune disorders are incomplete\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 2, 3, 5, 6, 16, 25, 27, 31]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [17, 18, 20, 29]},\n      {\"term_id\": \"GO:0042393\", \"supporting_discovery_ids\": [0, 3]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [4, 14]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 1, 2, 3, 18]},\n      {\"term_id\": \"GO:0005654\", \"supporting_discovery_ids\": [0, 2, 29]},\n      {\"term_id\": \"GO:0005694\", \"supporting_discovery_ids\": [1, 0]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 2, 3, 16, 25, 27, 28, 31]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [0, 3, 13, 38]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [5, 6, 7, 8, 20, 21, 26]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [9, 10, 30, 36]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [17, 19, 22]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [8, 18, 23]}\n    ],\n    \"complexes\": [\n      \"NuRD\",\n      \"7SK/HEXIM1/P-TEFb snRNP\",\n      \"mSWI/SNF\"\n    ],\n    \"partners\": [\n      \"HDAC1\",\n      \"HDAC2\",\n      \"SUV39H1\",\n      \"HEXIM1\",\n      \"GATA3\",\n      \"RUNX1\",\n      \"HP1A\",\n      \"RBBP7\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}